Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yanfang Wang, Fei Dong, Wei Wan, Zhenhao Zhang, Jing Wang, Hua Wang & Xiaoyan Ke. (2020) Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway. Hematology 25:1, pages 424-432.
Read now
Read now
Qing Fang, Siyi Jiang & Chengyuan Li. (2019) Evodiamine Selectively Inhibits Multiple Myeloma Cell Growth by Triggering Activation of Intrinsic Apoptosis Pathway. OncoTargets and Therapy 12, pages 11383-11391.
Read now
Read now
Gareth J. Morgan & Leo Rasche. (2018) Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinic. Expert Review of Hematology 11:7, pages 513-523.
Read now
Read now
Eli Muchtar, Shaji K. Kumar, Hila Magen & Morie A. Gertz. (2018) Diagnosis and management of smoldering multiple myeloma: the razor’s edge between clonality and cancer. Leukemia & Lymphoma 59:2, pages 288-299.
Read now
Read now
Articles from other publishers (2)
Ken Flanagan, Romika Kumari, Juho J. Miettinen, Staci L. Haney, Michelle L. Varney, Jacob T. Williams, Muntasir M. Majumder, Minna Suvela, Ana Slipicevic, Fredrik Lehmann, Nina N. Nupponen, Sarah A. Holstein & Caroline A. Heckman. (2022) The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death. HemaSphere 6:3, pages e687.
Crossref
Crossref
L. Rasche & N. Weinhold. (2018) Pathogenese des Multiplen MyelomsPathogenesis of multiple myeloma. Der Internist 60:1, pages 3-9.
Crossref
Crossref